17-44354523-G-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_198475.3(FAM171A2):c.1691C>A(p.Pro564Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,153,888 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P564L) has been classified as Uncertain significance.
Frequency
Consequence
NM_198475.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 68AN: 147952Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 258 AF XY: 0.00
GnomAD4 exome AF: 0.000241 AC: 242AN: 1005840Hom.: 4 Cov.: 31 AF XY: 0.000259 AC XY: 123AN XY: 474212 show subpopulations
GnomAD4 genome AF: 0.000446 AC: 66AN: 148048Hom.: 2 Cov.: 32 AF XY: 0.000693 AC XY: 50AN XY: 72192 show subpopulations
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at